Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Beta Bionics Inc (NASDAQ: BBNX) closed at $15.10 in the last session, down -3.76% from day before closing price of $15.69. In other words, the price has decreased by -$3.76 from its previous closing price. On the day, 3.17 million shares were traded. BBNX stock price reached its highest trading level at $15.74 during the session, while it also had its lowest trading level at $14.95.
Ratios:
We take a closer look at BBNX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.99 and its Current Ratio is at 4.62. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on February 24, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On February 24, 2025, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $26.
On February 24, 2025, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $28.Leerink Partners initiated its Outperform rating on February 24, 2025, with a $28 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 31 ’25 when Mensinger Mike bought 33,350 shares for $17.00 per share. The transaction valued at 566,950 led to the insider holds 59,019 shares of the business.
Mensinger Mike sold 13 shares of BBNX for $221 on Jan 31 ’25. The Chief Product Officer now owns 25,669 shares after completing the transaction at $17.00 per share. On Jan 31 ’25, another insider, Wellington Hadley Harbor Aggre, who serves as the 10% Owner of the company, bought 1,000,000 shares for $17.00 each. As a result, the insider paid 17,000,000 and bolstered with 3,901,599 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBNX now has a Market Capitalization of 654347968 and an Enterprise Value of 855293056. Its current Enterprise Value per Revenue stands at 16.127 whereas that against EBITDA is -21.724.
Stock Price History:
Over the past 52 weeks, BBNX has reached a high of $24.50, while it has fallen to a 52-week low of $13.64. The 50-Day Moving Average of the stock is -22.70%, while the 200-Day Moving Average is calculated to be -22.70%.
Shares Statistics:
According to the various share statistics, BBNX traded on average about 578.37K shares per day over the past 3-months and 740290 shares per day over the past 10 days. A total of 42.86M shares are outstanding, with a floating share count of 35.19M. Insiders hold about 18.65% of the company’s shares, while institutions hold 38.04% stake in the company. Shares short for BBNX as of 1740700800 were 945109 with a Short Ratio of 2.04, compared to 1738281600 on 209284.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
